Barr Pharmaceuticals was a global specialty pharmaceutical company that operated in more than 30 countries worldwide. Barr was engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals, and active pharmaceutical ingredients.
At Teva Pharmaceutical Industries, we improve people's health through our products, integrated R&D, generic medicines and global businesses.
Sep 5, 2003 ... Duramed Pharmaceuticals, Inc. SEASONALE.. (levonorgestrel / ethinyl estradiol tablets) 0.15 mg / 0.03 mg. Patients should be counseled that this product does not protect against HIV- infection (AIDS) and other sexually transmitted diseases. DESCRIPTION. Seasonale.. (levonorgestrel/ethinyl estradiol ...
View Duramed Pharmaceuticals Inc. contact information in addition to a brief company description provided by CareersInPharmaceutical.com.
Jun 30, 2001 ... The drug maker Barr Laboratories Inc. said yesterday that it would acquire Duramed Pharmaceuticals Inc. in a stock swap valued at about $589 million, adding to Barr's line of oral contraceptives and hormone products for women. Barr said it would exchange one share of its stock for 3.9032 shares of ...
(Acetazolamide). By Duramed Pharmaceuticals, Inc. | Last revised: 1 July 2008. For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angleclosure glaucoma where delay of surgery is desired in order to lower intraocular pressure. DIAMOX is also indicated for ...
Aug 14, 2006 ... WOODCLIFF LAKE, N.J., Aug. 14 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals , Inc. (NYSE: BRL) ("the Company") today announced that its subsidiary Duramed Pharmaceuticals, Inc. ("Duramed") and Shire plc (Nasdaq: SHPGY, TSX: SHQ, LSE: SHP) have signed a Product Acquisition Agreement for ...
Jul 21, 2011 ... By Donald Zuhn -- In Duramed Pharmaceuticals, Inc. v. Paddock Laboratories, Inc., the Federal Circuit today affirmed a decision by the District Court for the Southern District of New York granting summary judgment of noninfringement to Paddock Laboratories, Inc. with respect to U.S. Patent No. 5908638.